Titan Biotech allots 1,03,29,625 bonus shares of Rs. 2 each
BONUS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 26 Oct 2026, 10:10 AM IST · BSE ID: bd043ce3-5401-4c72-96dc-493c7fe0c99d
View Original BSE Filing (PDF)
💡
In Simple Terms
Titan Biotech issued bonus shares to shareholders as per the approved 1:4 ratio. Their total share capital has increased.
🤖 AI Summary
- Titan Biotech allotted 1,03,29,625 bonus equity shares of Rs. 2 each.
- The allotment ratio is 1 new share for every 4 existing shares.
- Record date for eligibility was October 23, 2026.
- This increases the company's paid-up equity share capital.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Bonus Shares Allotted
1,03,29,625
Face Value of Bonus Shares
Rs. 2/-
Record Date
October 23, 2026
Paid-up Equity Share Capital (Pre-Bonus)
Rs. 8,26,37,000/-
Increase in Paid-up Equity Share Capital
Rs. 2,06,59,250/-
🏢 How This Affects the Company
The allotment of bonus shares increases the company's paid-up equity share capital by Rs. 2,06,59,250/-. This does not involve an outflow of cash.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders. Bonus shares have been credited to eligible accounts.
👤
Who Is Affected
Shareholders whose names appeared in the Register of Members or Beneficial Owners as on October 23, 2026, received 1 new equity share for every 4 shares held.
🔍
Management Signal
The management is executing on corporate actions previously approved by shareholders.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Quarterly results for Q3 FY27 to show updated share capital.
Future company announcements on business growth and expansion.
Any further corporate actions or dividends announced by the board.
LOW RISK
This filing confirms a completed corporate action as per board and shareholder approvals.
💡 Investor Takeaway
Titan Biotech completed the allotment of 1,03,29,625 bonus equity shares of Rs. 2 each, on a 1:4 ratio, for shareholders recorded on October 23, 2026.
⚖️ Strengths & Concerns
✅ Positives
- Allotment of bonus shares enhances shareholder value without cash outflow.
- 1:4 bonus ratio increases number of shares held by eligible shareholders.
❓ Frequently Asked Questions
What is Titan Biotech's bonus share ratio?
Titan Biotech issued bonus equity shares in the ratio of 1:4, meaning 1 new share for every 4 existing shares.
How many bonus shares did Titan Biotech allot?
Titan Biotech allotted 1,03,29,625 fully paid-up bonus equity shares.
What is the face value of Titan Biotech's bonus shares?
The face value of each bonus equity share allotted by Titan Biotech is Rs. 2/-.
Who was eligible to receive Titan Biotech's bonus shares?
Shareholders whose names appeared in the Register of Members/Beneficial Owners as on October 23, 2026, were eligible.
How did the bonus issue affect Titan Biotech's share capital?
The bonus issue increased Titan Biotech's paid-up equity share capital by Rs. 2,06,59,250/-, from Rs. 8,26,37,000/- pre-bonus.
Questions based on this BSE filing only. For information purposes.